The underlined results are in favour of the earlier results where Chi et al.38revealed that dexmedetomidine may contribute to the regulation of the migration of breast cancer cells by up‐regulation of TMPRSS2. The gene discussed is TMPRSS2; the disease is breast carcinoma.